SR-9009 (Stenobolic) Driada Medical EU

SR-9009 (Stenobolic) – Driada Medical EU

The provided product is SR-9009, commonly known by the research name Stenabolic.¹ It is classified as a metabolic modulator and a REV-ERB agonist.² It is an investigational drug that is not approved for human use and is banned by the World Anti-Doping Agency (WADA) due to its performance-enhancing potential.³

Mechanism and Bodybuilding Benefits

SR-9009 is known for targeting the REV-ERB$alpha$ and REV-ERB$beta$ nuclear receptors.⁴ By activating these receptors, SR-9009 influences the body’s circadian rhythm and metabolism at a cellular level, earning it the designation of an “exercise mimetic”.⁵

• Metabolic Enhancement: SR-9009 promotes the use of stored fat as fuel by enhancing fatty acid oxidation and improving glucose metabolism.⁶ This dual action supports fat loss and contributes to a leaner body composition.⁷

• Endurance & Mitochondria: Research (primarily animal studies) indicates SR-9009 increases mitochondria counts and efficiency in skeletal muscle.⁸ This results in higher energy output, improved endurance, and reduced fatigue, mimicking the effects of exercise.

• Cardioprotection: Preclinical research suggests SR-9009 may exhibit cardioprotective properties, such as mitigating cardiac remodeling and promoting cardiac tissue repair.⁹

• Basal Metabolic Rate (BMR): It is thought to raise the BMR, enhancing overall energy expenditure even at rest.¹⁰

Usage and Dosage Guidelines (Illicit Use)

• Dosage: Common illicit dosages typically range from 10 mg to 30 mg per day.¹¹ The provided concentration is $10 text/text$.

• Frequency: Due to its short half-life (estimated to be very short, requiring frequent dosing), some users divide the daily dose into 2–3 administrations throughout the day to maintain consistent receptor activation.¹²

• Cycle Length: Commonly run for 8 to 12 weeks.¹³

• Timing: Often taken shortly before exercise to maximize energy expenditure and endurance during the training session.

Side Effects and Risks

SR-9009 has not been tested in humans, and its long-term safety profile is unknown.¹⁴

• Safety Status: SR-9009 is possibly unsafe when taken by mouth, as there is no reliable information regarding appropriate human dosing or safety.¹⁵

• Unknown Risks: Due to its role as a metabolic modulator and its influence on cellular processes, misuse carries risks that are not fully understood, including potential adverse effects on the heart.

Frequently Asked Questions (FAQ)

1. What is the main mechanism of SR-9009 that promotes fat loss?

SR-9009 promotes fat loss by acting as a REV-ERB agonist, which enhances fatty acid oxidation and increases energy expenditure.¹⁶ This activation essentially helps the body use stored fat as fuel more efficiently.¹⁷

2. Why is SR-9009 referred to as an “exercise mimetic”?

It is referred to as an exercise mimetic because it influences physiological systems in a way that replicates the effects of physical exercise at a cellular level, such as stimulating mitochondrial biogenesis (the creation of new energy-producing organelles) and improving endurance.¹⁸

3. Has SR-9009 been proven safe for use by athletes?

No. SR-9009 has not been adequately tested in humans, its long-term effects are unknown, and it is banned by the World Anti-Doping Agency (WADA) due to safety and performance-enhancing concerns.¹⁹

4. Why might users of oral SR-9009 choose to divide their dose throughout the day?

The compound has a very short half-life.²⁰ Users often divide the daily dose into 2–3 administrations to try and maintain more consistent blood levels and continuous activation of the REV-ERB receptors throughout the day.²¹